Consistent with the reviewer’s point, kynurenic acid exhibits context-dependent biological roles: it may act as an oncometabolite through AHR activation and immune modulation, yet it also demonstrates anti-proliferative effects in certain tumor models by inhibiting ERK1/2, p38 MAPK, and AKT pathways. The gene discussed is MAPK3; the disease is neoplasm.